Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
An initial set of studies went up this week at medRxiv, a new and somewhat controversial online outlet hosting preprinted clinical research reports—they haven’t yet been subject to peer review, much less journal editing—and the batch includes one dealing with AI.
Eyesight researchers have developed a machine-learning architecture whose best model, an ensemble classifier, achieved 93.4% accuracy in separating good candidates for corneal refractive surgery from patients likely to have post-surgery complications or poor outcomes.
Following total hip replacement, patients are well-served with AI-powered biofeedback that helps them rehab safely and effectively at home with occasional monitoring by a remote physical therapist.
A junior doctor in the U.K. is driving the development of a smartphone app that lets healthcare providers jettison their legacy pagers to communicate just as quickly but much more thoroughly and productively.
More adults are utilizing voice assistant devices powered by AI to help with their medication management, but not all devices are the same. According to new research published in Nature, Google Assistant outpaces its peers, including Amazon’s Alexa and Apple’s Siri voice assistants.
